Meilin Wang

机构：Southwest University, University of Michigan, Chung Shan Medical University Hospital · ORCID：0000-0003-4509-9561

发表论文 23 篇 · 总被引 436 次 · h-index 12

代表论文

A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo (2023 · Nature Chemical Biology · 被引 66)
Discovery of SMD-3040 as a Potent and Selective SMARCA2 PROTAC Degrader with Strong in vivo Antitumor Activity (2023 · Journal of Medicinal Chemistry · 被引 54)
Discovery of Exceptionally Potent, Selective, and Efficacious PROTAC Degraders of CBP and p300 Proteins (2023 · Journal of Medicinal Chemistry · 被引 53)
Discovery of ERD-3111 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity (2023 · Journal of Medicinal Chemistry · 被引 43)
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer (2024 · Journal of Medicinal Chemistry · 被引 36)
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression (2024 · Journal of Medicinal Chemistry · 被引 34)